Regulation of cAMP-phosphodiesterases by phosphatidic acid binding.
Grange
M
M
INSERM Unité 352, Biochimie & Pharmacologie Laboratoire, INSA-Lyon, France.
Sette
C
C
Prigent
A F
AF
Lagarde
M
M
Némoz
G
G
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D007984:Leydig Cell Tumor; D008297:Male; D010712:Phosphatidic Acids / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D013736:Testicular Neoplasms; D014162:Transfection; D014407:Tumor Cells, Cultured
D010712:Phosphatidic Acids; D011994:Recombinant Proteins; D011433:Propranolol; D000242:Cyclic AMP; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4